ArticleScientific reports2025
A deep learning framework for lysine 2-hydroxyisobutyrylation site prediction using evolutionary feature representation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lysine 2-hydroxyisobutyrylation (Khib) has emerged as a crucial Post-Translational Modification (PTM) with significant roles in diverse biological processes ranging from gene expression to metabolic regulation. Despite its importance, computational approaches for accurately predicting Khib sites remain limited. This study introduces BLOS-Khib, a deep-learning framework that utilizes evolutionary information encoded in the BLOSUM62 matrix within a Convolutional Neural Network (CNN) architecture for cross-species Khib site prediction. Through systematic optimization, we found that a 43-amino acid peptide length captures the optimal sequence context for prediction across six taxonomically diverse organisms. Comprehensive comparative analyses demonstrated BLOS-Khib competitive performance compared to existing methods, achieving notable Area Under the ROC Curve (AUC) values on independent test sets: human (0.913), wheat (0.892), T. gondii (0.893), rice (0.887), Candida albicans (0.885), and Botrytis cinerea (0.903). Our framework showed improved performance compared to state-of-the-art approaches, including traditional machine learning classifiers and alternative deep learning architectures. Sequence signature analysis revealed both conserved lysine-rich regions preceding modification sites and species-specific amino acid preferences at positions immediately flanking the target residue. Notably, our cross-species applicability experiments identified high transferability between evolutionarily distant organisms, ensuring the potential convergent evolution of Khib determinants. BLOS-Khib demonstrates competitive performance for PTM prediction, while providing evolutionary insights into the sequence determinants governing this emerging regulatory mechanism across diverse species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.